CATALYST FINANCIAL PARTNERS LLC

Position in JNJ — Johnson & Johnson

CIK 1927537 BOSTON, MA

Position in JNJ

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$6,315,471

+$52,919 QoQ

Shares Held

24,867

-2.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.23%

of 13F equity value

Holder Rank

#1,448

of 4,676 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $23,806,391 across 9 Drug Manufacturers - General names. JNJ ranks #2 (26.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,449	$7,735,124
2	JNJ	Johnson & Johnson This page	24,867	$6,315,471
3	ABBV	AbbVie Inc.	15,393	$3,873,494
4	MRK	Merck & Co., Inc.	20,205	$2,596,342
5	AMGN	Amgen Inc	3,386	$1,226,138
6	GILD	Gilead Sciences, Inc.	5,716	$722,159
7	PFE	Pfizer Inc	25,150	$605,612
8	BMY	Bristol Myers Squibb Co	8,894	$512,472

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,315,471	24,867	-2.9%	Shares	Sole	2026-07-30
2026-03-31	$6,262,552	25,620	+6.4%	Shares	Sole	2026-05-12
2025-12-31	$4,981,079	24,069	+10.0%	Shares	Sole	2026-02-04
2025-09-30	$4,058,287	21,887	+2.3%	Shares	Sole	2025-11-12
2025-06-30	$3,267,933	21,394	-24.0%	Shares	Sole	2025-08-14
2025-03-31	$4,668,893	28,153	-1.4%	Shares	Sole	2025-05-02
2024-12-31	$4,127,599	28,541	-5.7%	Shares	Sole	2025-01-30
2024-09-30	$4,906,366	30,275	-6.3%	Shares	Sole	2024-10-28
2024-06-30	$4,722,137	32,308	-13.5%	Shares	Sole	2024-07-25
2024-03-31	$5,905,707	37,333	-4.1%	Shares	Sole	2024-04-23
2023-12-31	$6,099,537	38,915	-11.6%	Shares	Sole	2024-02-07
2023-09-30	$6,854,869	44,012	-10.4%	Shares	Sole	2023-10-26
2023-06-30	$8,128,852	49,111	+275.5%	Shares	Sole	2023-08-02
2023-03-31	$2,027,245	13,079	+18.6%	Shares	Sole	2023-04-11
2022-12-31	$1,948,449	11,030	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.